Literature DB >> 24726386

The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.

Chris N Goulbourne1, Peter Gin1, Angelica Tatar1, Chika Nobumori1, Andreas Hoenger2, Haibo Jiang3, Chris R M Grovenor3, Oludotun Adeyo1, Jeffrey D Esko4, Ira J Goldberg5, Karen Reue6, Peter Tontonoz7, André Bensadoun8, Anne P Beigneux1, Stephen G Young9, Loren G Fong10.   

Abstract

Triglyceride-rich lipoproteins (TRLs) undergo lipolysis by lipoprotein lipase (LPL), an enzyme that is transported to the capillary lumen by an endothelial cell protein, GPIHBP1. For LPL-mediated lipolysis to occur, TRLs must bind to the lumen of capillaries. This process is often assumed to involve heparan sulfate proteoglycans (HSPGs), but we suspected that TRL margination might instead require GPIHBP1. Indeed, TRLs marginate along the heart capillaries of wild-type but not Gpihbp1⁻/⁻ mice, as judged by fluorescence microscopy, quantitative assays with infrared-dye-labeled lipoproteins, and EM tomography. Both cell-culture and in vivo studies showed that TRL margination depends on LPL bound to GPIHBP1. Notably, the expression of LPL by endothelial cells in Gpihbp1⁻/⁻ mice did not restore defective TRL margination, implying that the binding of LPL to HSPGs is ineffective in promoting TRL margination. Our studies show that GPIHBP1-bound LPL is the main determinant of TRL margination.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24726386      PMCID: PMC4143151          DOI: 10.1016/j.cmet.2014.01.017

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  37 in total

Review 1.  The role of the endothelium in myocardial lipoprotein dynamics.

Authors:  A Cryer
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

Review 2.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  Heparin-lipoprotein lipase interactions.

Authors:  T Olivecrona; G Bengtsson; S E Marklund; U Lindahl; M Höök
Journal:  Fed Proc       Date:  1977-01

4.  Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study.

Authors:  E J Blanchette-Mackie; H Masuno; N K Dwyer; T Olivecrona; R O Scow
Journal:  Am J Physiol       Date:  1989-06

5.  A molecular biology-based approach to resolve the subunit orientation of lipoprotein lipase.

Authors:  H Wong; D Yang; J S Hill; R C Davis; J Nikazy; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

6.  Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties.

Authors:  A Lookene; N B Groot; J J Kastelein; G Olivecrona; T Bruin
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

7.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

8.  Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity.

Authors:  M S Liu; Y Ma; M R Hayden; J D Brunzell
Journal:  Biochim Biophys Acta       Date:  1992-09-22

9.  Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100.

Authors:  A D Cardin; R L Barnhart; K R Witt; R L Jackson
Journal:  Thromb Res       Date:  1984-06-15       Impact factor: 3.944

Review 10.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.

Authors:  I J Goldberg
Journal:  J Lipid Res       Date:  1996-04       Impact factor: 5.922

View more
  69 in total

1.  GPIHBP1 autoantibody syndrome during interferon β1a treatment.

Authors:  Jun Eguchi; Kazuya Miyashita; Isamu Fukamachi; Katsuyuki Nakajima; Masami Murakami; Yuko Kawahara; Toru Yamashita; Yasuyuki Ohta; Koji Abe; Atsuko Nakatsuka; Mai Mino; Satoru Takase; Hiroaki Okazaki; Robert A Hegele; Michael Ploug; Xuchen Hu; Jun Wada; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2018-10-24       Impact factor: 4.766

2.  A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase.

Authors:  André Bensadoun; Charlene D Mottler; Chris Pelletier; Daniel Wu; Jane J Seo; Calvin S Leung; Oludotun Adeyo; Chris N Goulbourne; Peter Gin; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  Biochim Biophys Acta       Date:  2014-03-28

3.  Evidence for Two Distinct Binding Sites for Lipoprotein Lipase on Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein 1 (GPIHBP1).

Authors:  Mart Reimund; Mikael Larsson; Oleg Kovrov; Sergo Kasvandik; Gunilla Olivecrona; Aivar Lookene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

4.  The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.

Authors:  Katrine Z Leth-Espensen; Kristian K Kristensen; Anni Kumari; Anne-Marie L Winther; Stephen G Young; Thomas J D Jørgensen; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

5.  Novel GPIHBP1-independent pathway for clearance of plasma TGs in Angptl4-/-Gpihbp1-/- mice.

Authors:  Emily M Cushing; Kelli L Sylvers; Xun Chi; Shwetha K Shetty; Brandon S J Davies
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

Review 6.  JCL Roundtable: Hypertriglyceridemia due to defects in lipoprotein lipase function.

Authors:  W Virgil Brown; Ira J Goldberg; Stephen G Young
Journal:  J Clin Lipidol       Date:  2015-04-04       Impact factor: 4.766

7.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

8.  Intravascular triglyceride lipolysis becomes crystal clear.

Authors:  Jay D Horton
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-04       Impact factor: 11.205

9.  An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

Authors:  Christopher M Allan; Mikael Larsson; Xuchen Hu; Cuiwen He; Rachel S Jung; Alaleh Mapar; Constance Voss; Kazuya Miyashita; Tetsuo Machida; Masami Murakami; Katsuyuki Nakajima; André Bensadoun; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2016-08-05       Impact factor: 5.922

10.  The tissue distribution of lipoprotein lipase determines where chylomicrons bind.

Authors:  Roger Savonen; Michaela Hiden; Magnus Hultin; Rudolf Zechner; Sanja Levak-Frank; Gunilla Olivecrona; Thomas Olivecrona
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.